CMS Ventures, established in 2020, is the corporate venture arm of China Medical System Holdings, located in Cambridge, United Kingdom. The firm specializes in the biotechnology and life sciences sectors, focusing on therapeutics, diagnostics, medical devices, and digital health. CMS Ventures actively engages with seed-stage, early-stage, and later-stage companies, providing not only financial investment but also essential support through evaluation, coaching, mentoring, and advisory services. The firm aims to foster growth within the biotech and life sciences ecosystem, primarily within the United Kingdom.
Build on Bitcoin is a hybrid Layer-2 network Bitcoin blockchain
Pact
Seed Round in 2022
Pact is a fintech platform launched in 2021 that specializes in offering deep liquidity and low transaction fees for financial transactions. It operates as a non-custodial and decentralized platform, integrating financial assets to create a secure environment for users of varying wealth and experience levels. Pact's accessible smart contract functionality allows for efficient and cost-effective transactions, facilitating quick swaps within the cryptocurrency market. The platform is designed to serve as a central hub for liquidity on Algorand, enhancing the overall user experience in decentralized finance.
Qureight
Seed Round in 2021
Qureight is an imaging analytics company focused on enhancing the understanding of respiratory diseases, including Idiopathic Pulmonary Fibrosis and lung cancer. It develops a clinical data curation and analytics platform that integrates technology and life sciences to expedite drug development. By leveraging artificial intelligence, Qureight collaborates with hospitals, pharmaceutical companies, and software developers to analyze extensive clinical datasets. This approach aids in structuring medical images alongside clinical metadata, allowing healthcare professionals to identify novel biomarkers and deepen their comprehension of complex diseases and potential therapeutic strategies. The company is also working on a streamlined version of its analytical platform to further improve its capabilities in generating insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.